Daniel Spielsinger
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
Papers in
-
- Head and Neck Cancer Studies 7
-
- Occupational and environmental lung diseases 2
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Sean Matthew McBride (10 shared papers)Chiaojung Jillian Tsai (10 shared papers)Nadeem Riaz (10 shared papers)Nancy Y. Lee (5 shared papers)Eric Jeffrey Sherman (8 shared papers)Lara Ann Dunn (3 shared papers)Shrujal S. Baxi (1 shared paper)Alan Loh Ho (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (7 papers)International Journal of Cancer (1 paper)Clinical and Translational Radiation Oncology (1 paper)The Laryngoscope (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Daniel Spielsinger
9 papers receiving 369 citations
Daniel Spielsinger's Hit Papers
Peers
Comparison fields: 5 of 36
- Otorhinolaryngology 85
- Oncology 204
- Immunology 80
- Pulmonary and Respiratory Medicine 75
- Occupational Therapy 7
Countries citing papers authored by Daniel Spielsinger
This map shows the geographic impact of Daniel Spielsinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Spielsinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Spielsinger more than expected).
Fields of papers citing papers by Daniel Spielsinger
This network shows the impact of papers produced by Daniel Spielsinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Spielsinger. The network helps show where Daniel Spielsinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Spielsinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma Hit paper breakdown → | 2020 | 323 |
| 2 | 2018 | 22 | |
| 3 | 2018 | 7 | |
| 4 | 2017 | 6 | |
| 5 | 2019 | 4 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 3 | |
| 8 | 2018 | 1 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 1 | |
| 11 | 2021 | 0 | |
| 12 | 2017 | 0 |
About Daniel Spielsinger
Daniel Spielsinger is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 12 papers that have together received 372 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (7 papers), Head and Neck Surgical Oncology (2 papers), Occupational and environmental lung diseases (2 papers), Cancer Diagnosis and Treatment (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Radiation Dose and Imaging (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Disaster Response and Management (1 paper). The work is most often cited by research in Otorhinolaryngology (85 citations), Oncology (204 citations), Immunology (80 citations), Pulmonary and Respiratory Medicine (75 citations) and Occupational Therapy (7 citations). Daniel Spielsinger has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Sean Matthew McBride, Chiaojung Jillian Tsai, Nadeem Riaz, Nancy Y. Lee, Eric Jeffrey Sherman, Lara Ann Dunn, Shrujal S. Baxi, Alan Loh Ho, Jessica R. Flynn and Daniel Curtis McFarland. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Cancer, Clinical and Translational Radiation Oncology, The Laryngoscope and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.